HRP960279B1 - Hydroxylamine derivatives and pharmaceutical compositions - Google Patents

Hydroxylamine derivatives and pharmaceutical compositions

Info

Publication number
HRP960279B1
HRP960279B1 HR960279A HRP960279A HRP960279B1 HR P960279 B1 HRP960279 B1 HR P960279B1 HR 960279 A HR960279 A HR 960279A HR P960279 A HRP960279 A HR P960279A HR P960279 B1 HRP960279 B1 HR P960279B1
Authority
HR
Croatia
Prior art keywords
alkyl
pct
formula
group
compounds
Prior art date
Application number
HR960279A
Other languages
English (en)
Inventor
Laszlo Ueroegdi
Ede Marvanyos
Mihaly Barabas
Laszlo Jaszlits
Katalin Biro
Andrea Jednakovits
Erszbet Radvanyne Hegedues
Maria Kuerthy
Istvanne Udvardy Nagy
Original Assignee
Biorex Kutatoe Es Fejlesztoe R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kutatoe Es Fejlesztoe R filed Critical Biorex Kutatoe Es Fejlesztoe R
Publication of HRP960279A2 publication Critical patent/HRP960279A2/hr
Publication of HRP960279B1 publication Critical patent/HRP960279B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HR960279A 1995-06-15 1996-06-12 Hydroxylamine derivatives and pharmaceutical compositions HRP960279B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9501756A HU218480B (hu) 1995-06-15 1995-06-15 Hidroxilaminszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények

Publications (2)

Publication Number Publication Date
HRP960279A2 HRP960279A2 (en) 1997-12-31
HRP960279B1 true HRP960279B1 (en) 2002-02-28

Family

ID=10986948

Family Applications (1)

Application Number Title Priority Date Filing Date
HR960279A HRP960279B1 (en) 1995-06-15 1996-06-12 Hydroxylamine derivatives and pharmaceutical compositions

Country Status (23)

Country Link
US (1) US6002002A (ja)
EP (1) EP0832079B1 (ja)
JP (1) JP4083800B2 (ja)
KR (1) KR100444780B1 (ja)
AT (1) ATE215075T1 (ja)
AU (1) AU703163B2 (ja)
BR (1) BR9608929A (ja)
CA (1) CA2221689C (ja)
CZ (1) CZ295547B6 (ja)
DE (1) DE69620175T2 (ja)
DK (1) DK0832079T3 (ja)
ES (1) ES2174077T3 (ja)
HR (1) HRP960279B1 (ja)
HU (1) HU218480B (ja)
IL (1) IL122141A (ja)
IN (1) IN185781B (ja)
PL (1) PL185592B1 (ja)
PT (1) PT832079E (ja)
SI (1) SI0832079T1 (ja)
SK (1) SK282953B6 (ja)
WO (1) WO1997000251A1 (ja)
YU (1) YU49419B (ja)
ZA (1) ZA964978B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA64716C2 (en) * 1996-08-09 2004-03-15 Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells
RU2320330C2 (ru) 2002-01-11 2008-03-27 СиУайТиАрЭкс КОРПОРЕЙШН Производные карбоксамидина и их использование при лечении заболеваний сосудов
JP2007526912A (ja) 2004-01-30 2007-09-20 グレート・レークス・ケミカル・コーポレーション 製造方法並びにシステム、組成物、界面活性剤、モノマー単位、金属錯体、燐酸エステル、グリコール、水性皮膜形成フォーム、及びフォーム安定剤
US8318656B2 (en) 2007-07-03 2012-11-27 E. I. Du Pont De Nemours And Company Production processes and systems, compositions, surfactants, monomer units, metal complexes, phosphate esters, glycols, aqueous film forming foams, and foam stabilizers
KR101405103B1 (ko) * 2014-03-25 2014-06-10 재 남 우 레버식 수동개방기구를 구비하는 초고압 압축가스 개폐장치

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE369944C (de) * 1918-03-07 1923-02-24 Anilin Fabrikation Ag Verfahren zur Darstellung von Tetrahydronaphthalin
DE2651083A1 (de) * 1976-11-09 1978-05-18 Hoechst Ag Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung
EP0369944A1 (de) * 1988-11-18 1990-05-23 Ciba-Geigy Ag Substituierte Oxadiaminobutane
EP0495750A3 (en) * 1991-01-14 1992-09-16 Ciba-Geigy Ag Heterocyclic hydroxylamine

Also Published As

Publication number Publication date
SK282953B6 (sk) 2003-01-09
EP0832079B1 (en) 2002-03-27
DE69620175D1 (de) 2002-05-02
ATE215075T1 (de) 2002-04-15
HUT74621A (en) 1997-01-28
US6002002A (en) 1999-12-14
PL324197A1 (en) 1998-05-11
AU6237696A (en) 1997-01-15
CZ401597A3 (cs) 1998-04-15
DK0832079T3 (da) 2002-06-03
KR100444780B1 (ko) 2004-11-26
HU218480B (hu) 2000-09-28
AU703163B2 (en) 1999-03-18
IN185781B (ja) 2001-04-28
PL185592B1 (pl) 2003-06-30
SK171397A3 (en) 1998-06-03
SI0832079T1 (en) 2002-08-31
PT832079E (pt) 2002-07-31
YU49419B (sh) 2006-01-16
JPH11507662A (ja) 1999-07-06
HRP960279A2 (en) 1997-12-31
EP0832079A1 (en) 1998-04-01
ZA964978B (en) 1997-02-24
IL122141A0 (en) 1998-04-05
DE69620175T2 (de) 2002-08-22
CA2221689C (en) 2007-08-07
MX9710172A (es) 1998-07-31
CA2221689A1 (en) 1997-01-03
JP4083800B2 (ja) 2008-04-30
IL122141A (en) 2003-07-06
HU9501756D0 (en) 1995-08-28
WO1997000251A1 (en) 1997-01-03
BR9608929A (pt) 1999-06-15
ES2174077T3 (es) 2002-11-01
YU36996A (sh) 1998-11-05
KR19990022961A (ko) 1999-03-25
CZ295547B6 (cs) 2005-08-17

Similar Documents

Publication Publication Date Title
ATE128975T1 (de) Harnstoffderivate, verfahren zu ihrer herstellung und diese enthaltende medikamente.
NZ324007A (en) Quinazoline derivatives susbtituted by a phenyl and medicaments
HUT54149A (en) Process for producing new 3-brackets open 4-(1-substituted-4-piperazinyl)-butyl brackets closed-4-thiazolidinone derivatives and pharmaceutical compositions comprising such compounds
IE802612L (en) Bicyclo £2.2.1| heptane derivatives
CA2126465A1 (en) Inhibitor for restenosis after percutaneous coronary arterioplasty
GR3034769T3 (en) Triazole antifungal agents.
ES8401075A1 (es) &#34;procedimiento para preparar espiro (piperidino-oxobenzoxazinas) substituidas en posicion 1 anti-hipertensivas&#34;.
HU9300176D0 (en) Method for producing unsaturated 17beta-substituted 3-carboxy steroides
MY141488A (en) Hydroximic acid derivatives, processes for their preparation, and compositions comprising them
AU703163B2 (en) Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions
EP0335979A4 (en) Thienopyrimidine derivatives
MY124696A (en) Pde iv inhibiting pyridine derivatives.
HU9503807D0 (en) Pyridazinone derivatives with pharmaceutical activity
UA50722C2 (uk) Нітробензаміди, спосіб їх одержання (варіанти), фармацевтична композиція
NZ515278A (en) Halo derivatives of 9-deoxo-9a-aza-9a- homerythromycin A their salts and preparation process
DE69428206T2 (de) Chinolincarbonsäurederivate und ihre salze

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
PPPP Transfer of rights

Owner name: CYTRX CORPORATION, US

ODRP Renewal fee for the maintenance of a patent

Payment date: 20080521

Year of fee payment: 13

PBON Lapse due to non-payment of renewal fee

Effective date: 20090613